GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $2,767,000 | -87.9% | 40,797 | -89.6% | 0.00% | -88.0% |
Q2 2019 | $22,844,000 | -13.3% | 392,706 | +4.4% | 0.02% | -10.7% |
Q1 2019 | $26,350,000 | -3.2% | 376,161 | -11.0% | 0.03% | -12.5% |
Q4 2018 | $27,221,000 | +38.2% | 422,617 | +50.7% | 0.03% | +68.4% |
Q3 2018 | $19,692,000 | +125.4% | 280,427 | +61.8% | 0.02% | +111.1% |
Q2 2018 | $8,736,000 | +88.4% | 173,333 | +16.9% | 0.01% | +80.0% |
Q1 2018 | $4,638,000 | -4.1% | 148,223 | +4.9% | 0.01% | 0.0% |
Q4 2017 | $4,834,000 | +33.6% | 141,355 | +25.4% | 0.01% | +25.0% |
Q3 2017 | $3,617,000 | +68.6% | 112,716 | +71.1% | 0.00% | +33.3% |
Q2 2017 | $2,145,000 | +154.4% | 65,892 | +146.2% | 0.00% | +200.0% |
Q1 2017 | $843,000 | +57.6% | 26,766 | +47.0% | 0.00% | 0.0% |
Q4 2016 | $535,000 | -21.2% | 18,203 | -22.5% | 0.00% | 0.0% |
Q3 2016 | $679,000 | +151.5% | 23,485 | +125.3% | 0.00% | – |
Q2 2016 | $270,000 | -60.6% | 10,423 | -46.5% | 0.00% | -100.0% |
Q4 2015 | $686,000 | +130.2% | 19,489 | +78.4% | 0.00% | 0.0% |
Q4 2012 | $298,000 | – | 10,924 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RAMIUS ADVISORS LLC | 430,490 | $29,196,000 | 6.86% |
Baker Brothers Advisors | 9,244,665 | $626,973,000 | 4.26% |
ALPINE ASSOCIATES MANAGEMENT INC. | 789,540 | $53,546,000 | 1.75% |
HARVEST MANAGEMENT LLC | 18,500 | $1,255,000 | 1.75% |
HAVENS ADVISORS LLC | 28,000 | $1,899,000 | 1.73% |
Exane Asset Management | 30,000 | $2,034,600,000 | 1.56% |
EMORY UNIVERSITY | 9,506 | $645,000 | 1.27% |
IndexIQ Advisors LLC | 440,780 | $29,894,000 | 1.06% |
ALPHASIMPLEX GROUP, LLC | 37,537 | $2,546,000 | 0.97% |
Magnetar Financial LLC | 483,143 | $32,767,000 | 0.83% |